bioRxivNeurosciencePreprint
Language Models Learn Sentiment and Substance from 11,000 Psychoactive Experiences
Abstract
With novel hallucinogens poised to enter psychiatry, we lack a unified framework for quantifying which changes in consciousness are optimal for treatment. Using transformers (i.e. BERT) and 11,816 publicly-available drug testimonials, we first predicted 28-dimensions of sentiment across each narrative, validated with psychiatrist annotations. Secondly, BERT was trained to predict biochemical and demographic information from testimonials. Thirdly, canonical correlation analysis (CCA) linked 52 drugs receptor affinities with testimonial word usage, revealing 11 latent receptor-experience factors, mapped to a 3D cortical atlas. Together, these 3 machine learning methods elucidate a neurobiologically-informed, temporally-sensitive portrait of drug-induced subjective experiences. Different models results converged, revealing a pervasive distinction between lucid and mundane phenomena. MDMA was linked to "Love", DMT and 5-MeO-DMT to "Mystical Experiences", and other tryptamines to "Surprise", "Curiosity" and "Realization". Applying these models to real-time biofeedback, practitioners could harness them to guide the course of therapeutic sessions.
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Trips and Neurotransmitters: Discovering Principled Patterns across 6,850 Hallucinogenic Experiences
Galen Ballentine, Sam Freesun Friedman, Danilo Bzdok·Science AdvancesPeer-reviewed·Mar 16, 2022
- A dual-receptor model of serotonergic psychedelics
Arthur Juliani, Veronica Chelu, … Adam Safron·bioRxiv·Apr 12, 2024
- Distinct Modulatory Effects on Affective Biases by Different Serotonergic Psychedelics and MDMA in Male Rats: Possible Implications for Antidepressant Effects
Justyna K. Hinchcliffe, Julia Bartlett, … Emma S. J. Robinson·bioRxiv·Apr 22, 2026
- Synergistic, Multi-level Understanding of Psychedelics: Three Systematic Reviews and Meta-analyses of Their Pharmacology, Neuroimaging and Phenomenology
Kenneth Shinozuka, Katarina Jerotic, … Morten L. Kringelbach·Translational PsychiatryPeer-reviewed·Dec 4, 2024
- Whole-brain modelling supports the use of serotonergic psychedelics for the treatment of disorders of consciousness
Iván Mindlin, Ruben A Herzog, … Yonatan Sanz Perl·Communications BiologyPeer-reviewed·Sep 19, 2024
- Baseline power of theta oscillations predicts mystical-type experiences induced by DMT
Enzo Tagliazucchi, Federico Zamberlán, … Carla Pallavicini·bioRxiv·Mar 11, 2021